Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Risperidone vs Risperidone + Valproate for Schizophrenia with Hostility
NCT00308360Phase 4Completed
- Sponsor
- Nathan S. Kline Institute for Psychiatric Research
- Start
- Sep 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of risperidone in schizophrenia (2 arms), sponsored by Nathan S. Kline Institute for Psychiatric Research. Primary endpoints: Buss-Durkee Hostility Inventory at 8 weeks and Barratt Impulsiveness Scale at 8 weeks. Started Sep 1999; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00308360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308360.